Title : Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.

Pub. Date : 2019 Apr 26

PMID : 30810041






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Research has suggested that the upregulation of ERK signaling by the anticancer agent paclitaxel leads to acquired resistance of cells to this compound. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens
2 Plumbagin was shown to decrease levels of phosphorylated ERK in breast cancer cells and abrogated paclitaxel-induced ERK phosphorylation. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens
3 The role of ERK in plumbagin-mediated sensitization of breast cancer cells to paclitaxel was shown through the enhancement of the synergistic effect between compounds in cells with decreased ERK expression. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens
4 The role of ERK in plumbagin-mediated sensitization of breast cancer cells to paclitaxel was shown through the enhancement of the synergistic effect between compounds in cells with decreased ERK expression. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens
5 These results imply that plumbagin inhibits ERK activation in breast cancer cells, which plays a role in the sensitization of cells to paclitaxel-induced cell death. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens